AAAAAA
Results:
1-7
|
Results: 7
Authors:
OREMEK GM
EIGENBRODT E
RADLE J
ZEUZEM S
SEIFFERT UB
Citation: Gm. Oremek et al., VALUE OF THE SERUM LEVELS OF THE TUMOR-MARKER TUM2-PK IN PANCREATIC-CANCER, Anticancer research, 17(4B), 1997, pp. 3031-3033
Authors:
OREMEK GM
KRAMER W
SEIFFERT UB
JONAS D
Citation: Gm. Oremek et al., DIAGNOSTIC-VALUE OF SKELETAL AP AND PSA WITH RESPECT TO SKELETAL SCINTIGRAM IN PATIENTS WITH PROSTATIC DISEASE, Anticancer research, 17(4B), 1997, pp. 3035-3036
Authors:
OREMEK GM
SEIFFERT UB
Citation: Gm. Oremek et Ub. Seiffert, CYFRA-21-1 IS A SUITABLE MARKER IN THE DI AGNOSIS OF NONSMALL CELL LUNG-CANCER, Die medizinische Welt, 47(8), 1996, pp. 335-338
Authors:
OREMEK GM
VERING A
STEGMULLER M
SEIFFERT UB
Citation: Gm. Oremek et al., DIAGNOSTIC-VALUE OF MAMMARY SERUM ANTIGEN -MSA AS TUMOR-MARKER FOR BREAST-CANCER, Die medizinische Welt, 47(11), 1996, pp. 463-466
Authors:
OREMEK GM
SEIFFERT UB
Citation: Gm. Oremek et Ub. Seiffert, PHYSICAL-ACTIVITY RELEASES PROSTATE-SPECIFIC ANTIGEN (PSA) FROM THE PROSTATE-GLAND INTO BLOOD AND INCREASES SERUM PSA CONCENTRATIONS, Clinical chemistry, 42(5), 1996, pp. 691-695
Authors:
OREMEK GM
SEIFFERT UB
BEYERSDORF F
Citation: Gm. Oremek et al., KINETIC DIFFERENCES BETWEEN CREATINE KINASE-ISOENZYME MB (CK-MB) AND C-TROPONIN-T IN PATIENTS WITH MYOCARDIAL DAMAGE, Clinica chimica acta, 251(2), 1996, pp. 201-205
CYFRA-21-1 - A NEW TUMOR-MARKER OF THE CY TOKERATINE LINE FOR DIFFERENTIAL-DIAGNOSIS OF LUNG-DISEASE
Authors:
OREMEK GM
SEIFFERT UB
SIEKMEIER R
KIRSTEN R
Citation: Gm. Oremek et al., CYFRA-21-1 - A NEW TUMOR-MARKER OF THE CY TOKERATINE LINE FOR DIFFERENTIAL-DIAGNOSIS OF LUNG-DISEASE, Medizinische Klinik, 90(1), 1995, pp. 23-26
Risultati:
1-7
|